4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zai Lab Limited (9688) operates in the Biotechnology industry and is headquartered in Pudong, China with about 1,784 employees. Its market capitalization is roughly $19 billion. In the fiscal year ended 2025-12-31, 9688 reported $460M in revenue and ($176M) in net income.
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $460M | $399M | $267M | $215M | — |
| Gross Profit | $269M | $251M | $171M | $141M | — |
| Operating Income (EBIT) | ($224M) | ($274M) | ($374M) | ($393M) | — |
| Net Income | ($176M) | ($257M) | ($335M) | ($443M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $106M | $100M | $128M | $116M | $110M | — | — |
| Gross Profit | $58M | $61M | $65M | $69M | $67M | — | — |
| Operating Income (EBIT) | ($76M) | ($69M) | ($68M) | ($48M) | ($55M) | — | — |
| Net Income | ($51M) | ($51M) | ($50M) | ($36M) | ($41M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.2B | $1.2B | $1.0B | $1.2B | — |
| Total Liabilities | $457M | $345M | $240M | $174M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 9688 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms